Molecular modelling and design of radiolabelled complexes for melanoma diagnosis

Australian Journal of Chemistry

Volumn 57, Issue 1, 2004, Pages 87-96

  Tell Tuttle, C T ^a   Seabrook, Shane A ^a   Wise, Lauren E ^a   Katsifis, Andrew ^b   Knott, Robert B ^b   Yates, Brian F ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

^b AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSIS; DRUG PRODUCTS; POSITRON EMISSION TOMOGRAPHY; SKIN; TUMORS;

BINDING AFFINITIES; INTEGRIN RECEPTORS; MELANOMAS; RADIOLABELLED COMPOUNDS;

PROTEINS;

EID: 1142293203     PISSN: 00049425     EISSN: None     Source Type: Journal    
DOI: 10.1071/CH03165     Document Type: Article

References (64)

1. Sun and Skin-A Dangerous Combination 1997 (Australian Academy of Science: Canberra).
2. A. J. Souers, A. A. Virgilio, S. S. Schurer, J. A. Ellman, T. P. Kogan, H. E. West, W. Ankener, P. Vanderslice, Bioorg. Med. Chem. Lett. 1998, 8, 2297. doi: 10.1016/S00960-894X(98)00416-8
3. B. P. Eliceiri, D. A. Cheresh, J. Clin. Invest. 1999, 103, 1227.
4. A. Erdreicht-Epstein, H. Shimada, S. Groshen, M. Lui, L. S. Metelitsa, K. S. Kim, M. F. Stins, R. C. Seeger, et al., Cancer Res. 2000, 60, 712.
5. R. Pasqualini, E. Koivunen, E. Rousslahti, Nature Biotechnol. 1997, 15, 542.
6. K. E. Gottschalk, H. Kessler, Angew. Chem. Int. Ed. 2002, 41, 3767. doi: 10.1002/1521-3773(20021018)41:20<3767::AID=ANIE3767>3.0.CO;2-T
7. R. Haubner, D. Finsinger, H. Kessler, Angew. Chem. Int. Ed. 1997, 36, 1374.
8. G. Bitan, L. Scheibler, D. F. Mierke, M. Rosenblatt, M. Chorev, Biochem. 2000, 39, 11 014. doi:10.1021/BI000877A
9. H. Kessler, M. A. Dechanstreiter, E. Plankter, B. Matha, E. E. Lohof, G. Holzemann, A. Jonczyk, S. L. Goodman, J. Med. Chem. 1999, 42, 3033. doi:10.1021/JM970832G
10. K. C. Nicolaou, J. I. Trujillo, B. Jamdeleit, K. Chibale, M. Rosenfeld, B. Diefenbach, D. A. Cheresh, S. L. Goodman, Bioorg. Med. Chem. Lett. 1998, 6, 1185. doi:10. 1016/S0968-0896(98)00090-X
11. R. Haubner, H.-J. Wester, U. Reuning, R. Senekowitsch-Schmidtke, B. Diefenbach, H. Kessler, G. Stocklin, M. Schwaiger, J. Nucl. Med. 1999, 40, 1061.
12. R. Haubner, H.-J. Wester, F. Burkhart, R. Senekowitsch-Schmidtke, W. Weber, S. L. Goodman, H. Kessler, M. Schwaiger, J. Nucl. Med. 2001, 42, 326.
13. R. Haubner, H. J. Wester, W. A. Weber, C. Mang, S. I. Zeigler, S. L. Goodman, R. Senekowitsch-Schmidtke, H. Kessler, M. Schwaiger, Cancer Res. 2001, 61, 1781.
14. T. W. Ku, W. H. Miller, W. E. Bondell, K. F. Erhard, R. M. Keenan, A. J. Nichols, C. E. Peishhoff, J. M. Samanen, A. S. Wong, W. F. Huffman, J. Med. Chem. 1995, 38, 9.
15. R. M. Keenan, W. H. Miller, C. Kwon, F. E. Ali, J. F. Callahan, R. R. Calvo, S. Hwang, K. D. Kopple, et al., J. Med. Chem. 1997, 40, 2289. doi: 10.1021/JM970205R
16. M. S. Egbertson, J. J. Cook, B. Bednar, J. D. Prugh, R. A. Bednar, S. L. Gaul, R. J. Gould, G. D. Hartman, et al., J. Med. Chem. 1999, 42, 2409. doi: 10.1021/JM980722P
17. R. M. Keenan, W. H. Miller, L. S. Barton, W. E. Bondinell, R. D. Cousins, D. F. Eppley, S. Hwang, C. Kwon, et al., Bioorg. Med. Chem. Lett. 1999, 9, 1801. doi: 10.1016/S0960-894X(99)00282-6
18. R. M. Keenan, W. H. Miller, M. A. Lago, F. E. Ali, W. E. Bondinell, J. F. Callahan, R. R. Calvo, R. D. Cousins, et al., Bioorg. Med. Chem. Lett. 1998, 8, 3165. doi: 10.1016/SO960-894X(98)00555-1
19. A. Peyman, V. Wehner, J. Knolle, H. U. Stilz, G. Breipohl, K. Scheunemann, D. Carniato, J. Ruxer, et al., Bioorg. Med. Chem. Lett. 2000, 10, 179. doi: 10.1016/S0960-894X(99)00661-7
20. W. S. Craig, S. Cheng, D. G. Mullen, J. Blevitt, M. D. Pierschbacher, Biopolymers 1995, 37, 157.
21. J. L. Viney, S. Jones, H. H. Chiu, B. Lagrimas, M. E. Renz, L. G. Presta, D. Jackson, K. J. Hillan, S. Lew, S. Fong, J. Immunol. 1996, 157, 2488.
22. K. Burgess, D. Lim, S. A. Mousa, J. Med. Chem. 1996, 39, 4520. doi: 10.1021/JM960276A
23. H. Minoux, N. Moitessier, Y. Chapleur, B. Maigret, J. Comput.-Aided Mol. Des. 1998, 12, 533. doi: 10.1023/A: 1008024924329
24. D. S. Thorpe, H. Yeoman, A. W. E. Chan, V. Krchnak, M. Lebl, S. Felder, Biochem. Biophys. Res. Commun. 1999, 256, 537. doi: 10.1006/BBRC.1999.0374
25. E. Locardi, D. G. Mullen, R. H. Mattern, M. Goodman, J. Pept. Sci. 1999, 5, 491. doi: 10.1002/(SICI)1099-1387(199911)5:11<491::AID-PSC218>3.3. CO;2-#
26. N. Moitessier, S. Dufour, F. Chretien, J. P. Thiery, B. Maigret, Y. Chapleur, Bioorg. Med. Chem. 2001, 9, 511. doi: 10.1016/S0968-0896(00)00256-X
27. T. Kamata, Y. Takada, Int. J. Hematol. 2001, 74, 382.
28. K. E. Gottschalk, P. D. Adams, A. T. Brunger, H. Kessler, Protein Sci. 2002, 11, 1800. doi: 10.1110/PS.4120102
29. M. Miyashita, M. Akamatsu, Y. Hayashi, T. Ueno, Bioorg. Med. Chem. Lett. 2000, 10, 859. doi: 10.1016/S0960-894X(00)00113-X
30. J. Singh, H. van Vlijmen, W. C. Lee, Y. Liao, K. C. Lin, H. Ateeq, J. Cuervo, C. Zimmerman, et al., J. Comput.-Aided Mol. Des. 2001, 16, 201. doi: 10.1023/A:1020130418084
31. J. Singh, H. van Vlijmen, Y. S. Liao, W. C. Lee, M. Cornebise, M. Harris, I. H. Shu, A. Gill, et al., J. Med. Chem. 2002, 45, 2988. doi: 10.1021/JM020054E
32. D. C. Graham, R. B. Knott, B. F. Yates, manuscript in preparation.
33. Spartan 5.0.3x11 1991-1997 (Wavefunction: Irvine, CA).
34. N. L. Allinger, Y. H. Yuh, J. Lii, J. Am. Chem. Soc. 1989, 111, 8551.
35. K. E. Gilbert, PCModel ver. 7.0 2001 (Serena Software: Bloomington, IL).
36. M. Saunders, J. Am. Chem. Soc. 1987, 109, 3150.
37. In test calculations we used different starting geometries, different step sizes for the Cartesian coordinate deformations, and different numbers of trial structures. From these studies we determined that the parameters used in this work comprehensively sampled all relevant conformations.
38. T. Astley, C. T. T. Tuttle, Chirality Searcher ver. 1.3 2001 (University of Tasmania: Hobart).
39. The enantiomeric flipping is an artefact of the software. Although we have found the structures from the MM3 force field to be generally more reliable than those from the Sybyl force field, the enantiomeric flipping is certainly a disadvantage of the approach used here and in future work we will continue to critically evaluate which method to use for a particular problem.
40. J. Boström, P.-O. Norrby, T. Liljefors, J. Comput.-Aided Mol. Des. 1998, 12, 383. doi: 10.1023/A: 1008007507641
41. D. J. Diller, K. M. Merz, J. Comput.-Aided Mol. Des. 2002, 16, 105. doi: 10.1023/A:1016320106741
42. P. Walters, M. Stahl, Babel ver. 1.6 1992-1996 (University of Arizona: Tucson, AZ).
43. Sybyl ver. 6.7 2000 (Tripos Association: St. Louis, MO).
44. R. D. Cramer, D. E. Patterson, J. D. Bunce, J. Am. Chem. Soc. 1988, 110, 5959.
45. T. Weller, L. Alig, M. Beresini, B. Blackburn, S. Bunting, P. Hadvary, M. H. Muller, D. Knopp, et al., J. Med. Chem. 1996, 39, 3139. doi: 10.1021/JM9509298
46. K. Okumura, T. Shimazaki, Y. Aoki, H. Yamashita, J. Med. Chem. 1998, 41, 4036. doi:10.1021/JM9801859
47. Y. Hayashi, J. Katada, T. Harada, A. Tachiki, K. Iijima, Y. Takiguchi, M. Muramatsu, H. Miyazaki, et al., J. Med. Chem. 1998, 41, 2345. doi:10.1021/JM980126V
48. R. M. Keenan, J. F. Callahan, J. M. Samanen, W. E. Bondinell, R. R. Calvo, L. Chen, C. DeBrosse, L. S. Eggleston, et al., J. Med. Chem. 1999, 42, 545. doi:10.1021/JM980166Z
49. 50 values may not be strictly comparable.
50. C. T. T. Tuttle, Honours Thesis 2001 (University of Tasmania: Hobart).
51. A. Agarwal, P. P. Pearson, E. W. Taylor, H. B. Li, T. Dahlgren, M. Herslöf, Y. Yang, G. Lambert, et al., J. Med. Chem. 1993, 36, 4006.
52. 3 QSAR.
53. Sybyl Theory Manual 2000 (Tripos Association: St. Louis, MO).
54. It is unlikely that all the low-energy conformers of a molecule will be similar.
55. 3 activity for each compound in the low-energy window of conformers for the novel molecules. This shows that compound UTA1d has the conformer with the greatest activity and also the best selectivity, which is in agreement with the results obtained with the average predicted activities.
56. M. Aumailley, M. Gurrath, G. Muller, J. Calvete, R. Timpl, H. Kessler, FEBS Lett. 1991, 291, 50. doi:10.1016/0014-5793(91)81101-D
57. M. Ptaff, K. Tangemann, B. Muller, M. Gurrath, G. Muller, H. Kessler, R. Timpl, J. Engel, J. Biol. Chem. 1994, 269, 20 233.
58. R. Haubner, R. Gratias, B. Diefenbach, S. L. Goodman, A. Jonczyk, H. Kessler, J. Am. Chem. Soc. 1996, 118, 7461. doi:10.1021/JA9603721
59. R. Haubner, W. Schmitt, G. Holzemann, S. L. Goodman, A. Jonczyk, H. Kessler, J. Am. Chem. Soc. 1996, 118, 7881. doi:10.1021/JA9608757
60. M. A. Dechanstreiter, E. Plancker, B. Matha, E. Lohof, G. Holzemann, A. Jonczyk, S. L. Goodman, H. Kessler, J. Med. Chem. 1999, 42, 3033. doi:10.1021/JM970832G
61. J. W. Corbett, N. R. Graciani, S. A. Mousa, W. F. DeGrado, Bioorg. Med. Chem. Lett. 1997, 7, 1371. doi:10.1016/S0960-894X(97)00200-X
62. D. G. Batt, J. J. Petraitis, G. C. Houghton, D. P. Modi, G. A. Cain, M. H. Corjay, S. A. Mousa, P. J. Bouchard, et al., J. Med. Chem. 2000, 43, 41. doi:10.1021/JM990049J
63. J.-P. Xiong, T. Stehle, R. Zhang, A. Joachimiak, M. Frech, S. L. Goodman, M. A. Arnaout, Science 2002, 296, 151. doi:10.1126/SCIENCE.1069040
64. A referee has suggested that radiolabels in the ortho or meta positions could actually enhance the selectivity.